Episode Details

Scientists at Scripps Research have engineered a groundbreaking fentanyl vaccine that could revolutionize addiction treatment by blocking the drug before it reaches the brain, potentially slashing overdose risks and cravings. By tweaking fentanyl’s structure to preserve pain relief while eliminating respiratory depression, researchers created a vaccine that trains the immune system to neutralize the drug—and even its dangerous designer variants. Tested in mice, the vaccine produced potent antibodies that intercept fentanyl, offering a powerful shield for those in recovery or at high relapse risk. This isn’t a public health shield—it’s a targeted lifeline for those battling opioid dependence.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/0224b0bc0e56129e